[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351139-105":59,"doc-detail-351139-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cytokines-and-chemokines-as-emerging-biomarkers-and-therapeutic-targets-in-colorectal-cancer-narrative-review","Cytokines and Chemokines as Emerging Biomarkers and Therapeutic Targets in Colorectal Cancer - Narrative Review","","Colorectal cancer (CRC) presents major global health burdens due to rising incidence and high mortality, making early detection and effective therapy essential to improve patient outcomes. Cytokines and chemokines act as key regulators of the tumor microenvironment, shaping immune-cell recruitment, angiogenesis, proliferation, and metastasis. This narrative review compiles evidence on diagnostic and therapeutic uses of selected mediators, emphasizing biomarkers for early detection, prognosis, and treatment-response prediction. It also outlines emerging pathway-targeted strategies, including immune checkpoint inhibition, chemokine signaling modulation, and cytokine-based enhancement of antitumor immunity, focusing on IL-6, CXCL8, CCL2, and the CXCL12–CXCR4 axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cytokines-and-chemokines-as-emerging-biomarkers-and-therapeutic-targets-in-colorectal-cancer-narrative-review/351139/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cytokines-and-chemokines-as-emerging-biomarkers-and-therapeutic-targets-in-colorectal-cancer-narrative-review/351139.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are cytokines and chemokines important in colorectal cancer biology?","Question",{"text":112,"@type":113},"They modulate the tumor microenvironment by influencing immune-cell recruitment, angiogenesis, proliferation, and metastasis, which directly affects disease progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review position cytokines and chemokines for clinical use?",{"text":117,"@type":113},"It summarizes their potential as biomarkers for early detection, prognosis, and prediction of treatment response in colorectal cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"Which therapeutic approaches targeting cytokine and chemokine pathways are highlighted?",{"text":121,"@type":113},"The review discusses strategies such as immune checkpoint inhibitors, modulation of chemokine signaling, and cytokine-based approaches to enhance antitumor immunity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351139,1790196707,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Review  \nCytokines and Chemokines as Emerging Biomarkers and Therapeutic Targets in Colorectal Cancer—Narrative Review Weronika Sokólska , Monika Gudowska-Sawczuk  and Karolina Orywal *  \nAcademic Editor: Carmine Stolfi  \nReceived: 13 January 2026  \nRevised: 17 February 2026  \nAccepted: 17 February 2026  \nPublished: 19 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Biochemical Diagnostics, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bialystok, Poland; [weronika.sokolska@sd.umb.edu.pl](weronika.sokolska@sd.umb.edu.pl) (W.S.); [monika.gudowska-sawczuk@umb.edu.pl](monika.gudowska-sawczuk@umb.edu.pl) (M.G.-S.)  \n* Correspondence: [karolina.orywal@umb.edu.pl](karolina.orywal@umb.edu.pl); Tel.: +48-85-831-8587; Fax: +48-85-831-8585  \nAbstract  \nColorectal cancer (CRC) is a significant global health challenge, characterized by an increasing incidence rate and high mortality rate. Early detection and effective treatment are crucial to improving patients’ quality of life. Cytokines and chemokines are key modulators of the tumor microenvironment, influencing the recruitment of immune cells, angiogenesis, proliferation, and metastasis. This narrative review summarizes the current knowledge regarding the potential diagnostic and therapeutic applications of selected cytokines and chemokines in CRC. We discuss their potential as biomarkers for early detection, prognosis, and prediction of treatment response. We also highlight emerging therapeutic strategies targeting cytokine and chemokine pathways, including immune checkpoint inhibitors, modulation of chemokine signaling, and the direct use of cytokines to enhance antitumor immunity, with particular emphasis on interleukin-6 (IL-6), C-X-C motif chemokine ligand 8 (CXCL8), C-C motif chemokine ligand 2 (CCL2), and the C-X-C motif chemokine ligand 12 (CXCL12)–C-X-C chemokine receptor type 4 (CXCR4) axis, which show consistent associations with tumor stage, metastasis, and treatment response. Integrating cytokineand chemokine-based approaches with combination therapies could lead to more effective conventional treatments. In summary, this review emphasizes the potential of cytokines and chemokines as diagnostic tools and therapeutic targets, paving the way for more personalized and effective treatment strategies for colorectal cancer.  \nKeywords: colorectal cancer; cytokines; chemokines; tumor microenvironment; biomarkers; immunotherapy; CXCL12–CXCR4; IL-2; IL-12  \n1. Introduction  \nColorectal cancer (CRC) is the third most frequently diagnosed cancer and the second leading cause of cancer mortality in both men and women. The incidence of this type of cancer is increasing, and experts expect the incidence of CRC to increase by up to 60% by 2030, which will pose a significant challenge and a greater burden on healthcare systems worldwide [1] . CRC is a latent disease entity that often occurs in an advanced stage. It is characterized by a slow, multi-stage process that takes approximately 5–10 years from the appearance of precancerous lesions to the development of colorectal cancer [2] . Most cases develop from benign precancerous polyp lesions following the somatic inactivation of the tumor suppressor Adenomatous Polyposis Coli (APC) and progress through a series of genetic and epigenetic changes that accumulate over years or decades, involving mutations in Kirsten rat sarcoma virus oncogene homologue (KRAS)/v-raf murine sarcoma viral oncogene  \nhomolog B1 (BRAF), SMAD family member 4 (SMAD)/transforming growth factor beta receptor 2 (TGFBR2), tumor protein p53 (p53), and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) [3] .  \nMany factors, including patient-related factors and familial, genetic, and env","cbCairNyraZhP992","https://ap.wps.com/l/cbCairNyraZhP992","pdf",1284050,24,"English","# Abstract\n# 1. Introduction","[{\"question\":\"Why are cytokines and chemokines important in colorectal cancer biology?\",\"answer\":\"They modulate the tumor microenvironment by influencing immune-cell recruitment, angiogenesis, proliferation, and metastasis, which directly affects disease progression.\"},{\"question\":\"How does the review position cytokines and chemokines for clinical use?\",\"answer\":\"It summarizes their potential as biomarkers for early detection, prognosis, and prediction of treatment response in colorectal cancer.\"},{\"question\":\"Which therapeutic approaches targeting cytokine and chemokine pathways are highlighted?\",\"answer\":\"The review discusses strategies such as immune checkpoint inhibitors, modulation of chemokine signaling, and cytokine-based approaches to enhance antitumor immunity.\"}]","Cytokines and Chemokines as Emerging Biomarkers and Therapeutic Targets in Colorectal Cancer - Narrative Review | PDF",1790092806,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb573e992a36d784620627f9157d904e.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0648764d37f7ce9fb5bde0fec77219b4.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5839d575d4634596bc56287385b02b62.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c99e68d7a351606084c4a15f8767589.webp",980,1385]